» Authors » Quan Duy Vo

Quan Duy Vo

Explore the profile of Quan Duy Vo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 9
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vo Q, Nakamura K, Saito Y, Iida T, Yoshida M, Amioka N, et al.
Cells . 2025 Jan; 13(24. PMID: 39768137
Induced pluripotent stem cell (iPSC)-derived biological pacemakers have emerged as an alternative to traditional electronic pacemakers for managing cardiac arrhythmias. While effective, electronic pacemakers face challenges such as device failure,...
2.
Le D, Pham G, Vo Q
Egypt Heart J . 2024 Dec; 76(1):154. PMID: 39617858
Background: Primary percutaneous coronary intervention (PCI) can dislodge atherosclerotic debris, risking microvascular embolism. Thrombus aspiration (TA) before stenting in ST-segment elevation myocardial infarction (STEMI) patients has been linked to reduced...
3.
Le D, Bui H, Vo Q
Interv Cardiol . 2024 Sep; 19:e17. PMID: 39309299
COVID-19 patients may experience acute mesenteric ischaemia. Identifying acute mesenteric ischaemia is challenging, particularly as initial symptoms are often vague and easily overlooked. Early detection and immediate intervention to restore...
4.
Le D, Bui H, Vu Y, Vo Q
Regen Med . 2024 Sep; 19(9-10):497-509. PMID: 39263954
Heart failure (HF) causes over 266,400 deaths annually. Despite treatment advancements, HF mortality remains high. Induced pluripotent stem cells (iPSCs) offer promising new options. This review assesses iPSC-based treatments for...
5.
Le D, Bui H, Vo Q
Interv Cardiol . 2024 Jun; 19:e08. PMID: 38915851
Background: Left main (LM) coronary artery disease (CAD) is a severe condition that can lead to severe outcomes. Treatment options include medication, coronary artery bypass graft surgery (CABG) and percutaneous...
6.
Vo Q, Saito Y, Ida T, Nakamura K, Yuasa S
PLoS One . 2024 May; 19(5):e0302537. PMID: 38771829
Background: Stem cell research, particularly in the domain of induced pluripotent stem cell (iPSC) technology, has shown significant progress. The integration of artificial intelligence (AI), especially machine learning (ML) and...
7.
Vo Q, Saito Y, Nakamura K, Iida T, Yuasa S
Int J Mol Sci . 2024 Jan; 25(2). PMID: 38256060
Ischemic heart disease (IHD) poses a significant challenge in cardiovascular health, with current treatments showing limited success. Induced pluripotent derived-cardiomyocyte (iPSC-CM) therapy within regenerative medicine offers potential for IHD patients,...